Pediatric Septic Shock Therapies Perform Equally Well
Data on 9,000 children with septic shock shows no difference in kidney outcomes between two common types of IV fluids used for emergency resuscitation.
Data on 9,000 children with septic shock shows no difference in kidney outcomes between two common types of IV fluids used for emergency resuscitation.
Data on 9,000 children with septic shock shows no difference in kidney outcomes between two common types of IV fluids used for emergency resuscitation.
Read MoreA two-time NASCAR champion driver died Thursday from severe pneumonia that progressed into sepsis, according to multiple media outlets.
Read MoreA new analysis shows that early use of rapid testing for bloodstream infections reduces sepsis progression and healthcare expenses.
Read MoreSepsis reduced 30-day survival in patients with less severe acute kidney injury but was paradoxically associated with higher survival rates in the most severely ill AKI patients.
Read MoreFindings suggest that the endothelial gene ALOX15 gene protects against sepsis-induced lung injury.
Read MoreEsmolol showed significant reductions in 28-day mortality, ICU mortality, and other benefits in adults with septic shock.
Read MoreMulticenter study shows rapid the sepsis diagnostic IntelliSep enabled an increase in safe emergency department discharges, easing inpatient bed shortages without increasing 30-day return visits.
Read MoreDoctors have successfully treated a child in severe septic shock and multiorgan failure with a novel therapeutic tool called the selective cytopheretic device.
Read MoreResearchers compared Area Deprivation Index (ADI) to Healthy Places Index (HPI) in order to assess neighborhood disadvantage as a predictor of in-hospital mortality among sepsis patients.
Read MoreAdults who were hospitalized for a severe infection, such as respiratory infections or sepsis, were more than twice as likely to develop heart failure years later.
Read MorePatients hospitalized for respiratory infections or sepsis had more than double the odds of heart failure later in life.
Read MoreA protein called angiopoietin-2 (ANGPT2) can both inhibit and encourage blood vessel changes critical for sepsis.
Read MoreSevere respiratory infections and sepsis more than double the risk of heart failure, research shows.
Read MoreThe test can both identify bacterial and viral infections and assess the need for critical care in patients with suspected infection or sepsis.
Read MoreResearchers found that medical ozone therapy can improve lung function in mice with sepsis-induced acute lung injury.
Read MoreThe FDA has granted Breakthrough Device Designation to a sepsis risk assessment test designed to support rapid clinical decisions.
Read MoreThe funding will accelerate the rollout of a rapid diagnostic test that helps emergency departments quickly identify and treat sepsis.
Read MoreThe COVID-19 pandemic led to a noticeable rise in sepsis-related hospitalizations, hospital costs, and in-hospital mortality, particularly for patients with a COVID-19 diagnosis.
Read MoreThe newly cleared test detects sepsis earlier than current standards by measuring levels of the pancreatic stone protein biomarker.
Read MoreThe AI tool actively involves clinicians by identifying missing patient data and suggesting the most critical information needed to improve sepsis risk predictions.
Read MorebioMérieux received US FDA 510(k) clearance for its Vitek Reveal AST System, which reports results directly from positive blood cultures.
Read MoreIn patients most at risk for organ damage, the drug lessened the need for assisted ventilation and showed a slight decrease in mortality.
Read MoreRoche will commercially distribute Prenosis Inc’s Sepsis ImmunoScore, the first-ever FDA De Novo authorized AI diagnostic tool for sepsis.
Read MoreAdministering azithromycin to pregnant women who deliver vaginally is a cost-saving treatment for reducing maternal sepsis, death or infection in developing countries.
Read More